Cargando…

Update Breast Cancer 2019 Part 3 – Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel

The treatment of breast cancer patients in a curative situation is special in many ways. The local therapy with surgery and radiation therapy is a central aspect of the treatment. The complete elimination of tumour cells at the site of the primary disease must be ensured while simultaneously strivin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolberg, Hans-Christian, Schneeweiss, Andreas, Fehm, Tanja N., Wöckel, Achim, Huober, Jens, Pontones, Constanza, Titzmann, Adriana, Belleville, Erik, Lux, Michael P., Janni, Wolfgang, Hartkopf, Andreas D., Taran, Florin-Andrei, Wallwiener, Markus, Overkamp, Friedrich, Tesch, Hans, Ettl, Johannes, Lüftner, Diana, Müller, Volkmar, Schütz, Florian, Fasching, Peter A., Brucker, Sara Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529230/ https://www.ncbi.nlm.nih.gov/pubmed/31148847 http://dx.doi.org/10.1055/a-0887-0861

Ejemplares similares

Update Breast Cancer 2019 Part 4 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer
por: Schütz, Florian, et al.
Publicado: (2019)

Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer
por: Welslau, Manfred, et al.
Publicado: (2019)

Translational Highlights in Breast and Ovarian Cancer 2019 – Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy
por: Hartkopf, Andreas D., et al.
Publicado: (2019)

Update Breast Cancer 2020 Part 4 – Advanced Breast Cancer
por: Tesch, Hans, et al.
Publicado: (2020)

Update Breast Cancer 2017 – Implementation of Novel Therapies
por: Lux, Michael P., et al.
Publicado: (2017)

Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice
por: Janni, Wolfgang, et al.
Publicado: (2019)

Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers
por: Taran, Florin-Andrei, et al.
Publicado: (2018)

Update Breast Cancer 2019 Part 1 – Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer
por: Hartkopf, Andreas D., et al.
Publicado: (2019)

Update Breast Cancer 2020 Part 1 – Early Breast Cancer: Consolidation of Knowledge About Known Therapies
por: Schneeweiss, Andreas, et al.
Publicado: (2020)

Update Breast Cancer 2018 (Part 2) – Advanced Breast Cancer, Quality of Life and Prevention
por: Schneeweiss, Andreas, et al.
Publicado: (2018)

Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics
por: Lüftner, Diana, et al.
Publicado: (2020)

Update Breast Cancer 2020 Part 3 – Early Breast Cancer
por: Huober, Jens, et al.
Publicado: (2020)

Update Breast Cancer 2018 (Part 4) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer
por: Müller, Volkmar, et al.
Publicado: (2018)

Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer
por: Wöckel, Achim, et al.
Publicado: (2018)

Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
por: Lux, Michael P., et al.
Publicado: (2018)

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany
por: Huebner, Hanna, et al.
Publicado: (2020)

Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
por: Michel, Laura L., et al.
Publicado: (2020)

Return of individual genomic research results within the PRAEGNANT multicenter registry study
por: Huebner, Hanna, et al.
Publicado: (2022)

Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
por: Lüftner, Diana, et al.
Publicado: (2022)

Correction: Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
por: Lüftner, Diana, et al.
Publicado: (2022)

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
por: Lux, Michael P., et al.
Publicado: (2021)

Update Breast Cancer 2022 Part 4 – Advanced-Stage Breast Cancer
por: Aktas, Bahriye, et al.
Publicado: (2022)

Update Breast Cancer 2022 Part 3 – Early-Stage Breast Cancer
por: Fehm, Tanja N., et al.
Publicado: (2022)

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
por: Schneeweiss, Andreas, et al.
Publicado: (2020)

Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer
por: Lux, Michael P., et al.
Publicado: (2023)

Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer
por: Hartkopf, Andreas D., et al.
Publicado: (2023)

Update Breast Cancer 2021 Part 4 – Prevention and Early Stages
por: Thomssen, Christoph, et al.
Publicado: (2022)

Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies
por: Kolberg, Hans-Christian, et al.
Publicado: (2023)

Update Breast Cancer 2022 Part 2 – Advanced Stage Breast Cancer
por: Müller, Volkmar, et al.
Publicado: (2022)

Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
por: Laakmann, Elena, et al.
Publicado: (2020)

Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
por: Laakmann, Elena, et al.
Publicado: (2020)

Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer
por: Fehm, Tanja N., et al.
Publicado: (2023)

Update Breast Cancer 2022 Part 6 – Advanced-Stage Breast Cancer
por: Lüftner, Diana, et al.
Publicado: (2023)

Update Breast Cancer 2022 Part 1 – Early Stage Breast Cancer
por: Welslau, Manfred, et al.
Publicado: (2022)

Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT
por: Engler, Tobias, et al.
Publicado: (2022)

Update Breast Cancer 2021 Part 1 – Prevention and Early Stages
por: Stickeler, Elmar, et al.
Publicado: (2021)

Update Breast Cancer 2021 Part 2 – Advanced Stages, Long-Term Consequences and Biomarkers
por: Ditsch, Nina, et al.
Publicado: (2021)

Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients
por: Hartkopf, Andreas D, et al.
Publicado: (2017)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Update Breast Cancer 2021 Part 3 – Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel
por: Fehm, Tanja N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ocf1uftrahs706nav0pvuorvqf